SMN Corporation Logo

SMN Corporation

A marketing tech firm providing AI-powered, data-driven solutions for advertisers and agencies.

6185 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
品川区大崎二丁目11番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

SMN Corporation, a Sony Group company formerly known as So-net Media Networks, is a marketing technology firm. It develops and provides data-driven solutions for digital marketing challenges, primarily serving advertisers and agencies. The company's core offerings are powered by proprietary technologies in big data processing and artificial intelligence, including its AI engine "VALIS-Engine" and the demand-side platform (DSP) "Logicad." SMN's services encompass a range of solutions from data collection and analysis to programmatic advertising management and media planning, designed to optimize marketing effectiveness.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-30 08:51
Registration Form
確認書
Japanese 8.1 KB
2025-06-30 08:47
Annual Report
訂正有価証券報告書-第28期(2024/04/01-2025/03/31)
Japanese 605.8 KB
2025-06-24 10:00
Post-Annual General Meeting Information
臨時報告書
Japanese 25.7 KB
2025-06-20 08:35
Governance Information
内部統制報告書-第28期(2024/04/01-2025/03/31)
Japanese 24.7 KB
2025-06-20 08:34
Registration Form
確認書
Japanese 8.0 KB
2025-06-20 08:34
Annual Report
有価証券報告書-第28期(2024/04/01-2025/03/31)
Japanese 993.4 KB
2025-05-20 08:39
Regulatory News Service
臨時報告書
Japanese 18.0 KB
2024-11-06 07:56
Regulatory News Service
臨時報告書
Japanese 18.4 KB
2024-11-06 07:55
Report Publication Announcement
確認書
Japanese 8.0 KB
2024-11-06 07:54
Interim Report
半期報告書-第28期(2024/04/01-2025/03/31)
Japanese 184.2 KB
2024-08-05 09:16
Regulatory News Service
臨時報告書
Japanese 19.0 KB
2024-06-28 09:25
Post-Annual General Meeting Information
臨時報告書
Japanese 22.1 KB
2024-06-26 09:43
Governance Information
内部統制報告書-第27期(2023/04/01-2024/03/31)
Japanese 24.9 KB
2024-06-26 09:42
Registration Form
確認書
Japanese 8.0 KB
2024-06-26 09:41
Annual / Quarterly Financial Statement
有価証券報告書-第27期(2023/04/01-2024/03/31)
Japanese 1.0 MB

Automate Your Workflow. Get a real-time feed of all SMN Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SMN Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.
Japan 4594
Brilliant Future AB Logo
A data-driven survey platform to measure and improve employee & customer experiences.
Sweden BRILL
b-style holdings,Inc. Logo
Offers flexible staffing for homemakers and specialized recruitment for skilled professionals.
Japan 302A
BTS Group Logo
Helps organizations execute strategy via experiential learning for leadership and sales teams.
Sweden BTS
B.U Technology Logo
Commercializes university research via IP management, licensing, and new venture creation.
South Korea 230980
Advancing high-grade copper and precious metal projects from discovery to production.
Canada N/A
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.